Using Connected Health to Increase Lung Cancer Screening

NACompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Lung Cancer
Interventions
BEHAVIORAL

Referral to Telemedicine LCS Counseling Visit

Patients in the intervention arm will be invited to complete a telemedicine LCS counseling visit, and asked for permission to be referred directly to the LCS navigator to help schedule an appointment. They will also be given the option to directly contact the LCS navigator. Telemedicine counseling visits will be conducted using established clinical procedures for virtual or telephone visits at Penn Medicine. In accordance with reimbursement policies for lung cancer screening, these visits will be conducted by a physician or nurse practitioner within the Lung Cancer Screening Program at Penn Medicine. Counseling visits are covered without co-pay as standalone visits according to USPSTF guidelines and costs will not be covered by the study. LCS is an evidence-based practice and considered standard of care for those who are eligible and desire to be screened. Clinicians retain full control on how to conduct LCS counseling or LDCT in this trial.

BEHAVIORAL

Usual Care

Patients in the usual care arm will be provided with contact information for the Penn LCS Program and encouraged to discuss LCS with their providers.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

Abramson Cancer Center at Penn Medicine

OTHER

lead

University of Pennsylvania

OTHER

NCT04612946 - Using Connected Health to Increase Lung Cancer Screening | Biotech Hunter | Biotech Hunter